{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:19:47Z","timestamp":1790914787307,"version":"4.1.0"},"reference-count":33,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"\n Importance<\/jats:title>\n Annual rates of first intracranial hemorrhage (ICH) from unruptured brain arteriovenous malformations (AVMs) are often quoted as 2% to 4% in clinical practice. Precise estimates and risk factors are unavailable to inform treatment decisions.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n To provide estimates of rates and risk factors for first ICH in a large cohort study of unruptured brain AVMs.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n The Multicenter Arteriovenous Malformation Research Study (MARS) included data from 9 cohorts, each contributing 100 or more unruptured brain AVMs. The study was conducted from 2017 to 2023 with retrospective and prospective data collection for existing cohorts and\/or new recruitment. This was an international study (2 population-based and 7 referral-based cohorts) that included participants diagnosed with an unruptured brain AVM.<\/jats:p>\n <\/jats:sec>\n \n Exposures<\/jats:title>\n Demographic, clinical, and angiographic characteristics.<\/jats:p>\n <\/jats:sec>\n \n Main Outcome and Measure<\/jats:title>\n The primary outcome was time to first ICH after diagnosis of unruptured brain AVM. Data were collected using standardized definitions; missing data were imputed. Cox regression analysis was performed, censoring at first brain AVM treatment, death, or last visit, and allowing baseline hazards to vary by cohort.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 3225 individuals were eligible for participation in this study. After 195 exclusions, 3030 participants (median [IQR] age, 38 [25-50] years; 1524 female [50.3%]) were included. Among 2989 participants with unruptured brain AVMs, 1333 (45%) presented with seizure. The median (IQR) maximal brain AVM diameter was 3.1 (2.2-4.4) cm, 248 of 2466 AVMs (10%) had exclusively deep venous drainage, 297 of 2690 (11%) were in supratentorial deep or cerebellar locations, and 457 of 2440 (19%) had associated arterial aneurysms. First ICH occurred in 159 participants over 11\u202f339 person-years of follow-up for an ICH rate of 1.40 (95% CI, 1.20-1.64) per 100 person-years. Significant independent risk factors included (1) increasing age category at diagnosis (hazard ratio [HR], 0.87; 95% CI, 0.53-1.41 for those aged 20 to 39 years; HR, 1.23; 95% CI, 0.74-2.04 for those aged 40 to 59 years; and HR, 2.01; 95% CI, 1.14-3.57 for those aged 60 years vs younger than 20 years;\n P<\/jats:italic>\n \u2009=\u2009.008), (2) presence of associated aneurysms (HR, 1.66; 95% CI, 1.06-2.59;\n P<\/jats:italic>\n \u2009=\u2009.03), and (3) cerebellar or supratentorial deep location (HR, 1.87; 95% CI, 1.16-3.00;\n P<\/jats:italic>\n \u2009=\u2009.01).\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n The annual ICH rate from unruptured brain AVM was lower than that commonly cited in clinical practice. Increasing age, associated arterial aneurysms, and cerebellar or supratentorial deep brain AVM location were associated with risk of first ICH. These results may be used to counsel patients about the natural history of unruptured brain AVMs.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamaneurol.2025.3581","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T15:00:38Z","timestamp":1759762838000},"page":"1274","source":"Crossref","is-referenced-by-count":13,"title":["Risk of Future Hemorrhage From Unruptured Brain Arteriovenous Malformations"],"prefix":"10.1001","volume":"82","author":[{"given":"Helen","family":"Kim","sequence":"first","affiliation":[{"name":"Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, University of California, San Francisco"},{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Nelson","sequence":"additional","affiliation":[{"name":"Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"McCulloch","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hess","sequence":"additional","affiliation":[{"name":"Department of Radiology and Biomedical Imaging, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven W.","family":"Hetts","sequence":"additional","affiliation":[{"name":"Department of Radiology and Biomedical Imaging, University of California, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Flemming","sequence":"additional","affiliation":[{"name":"Department of Neurology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"II","given":"Giuseppe S.","family":"Lanzino","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Koroknay-P\u00e1l","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Helsinki University Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Oulasvirta","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Helsinki University Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aki","family":"Laakso","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Helsinki University Hospital, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Lawton","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay P.","family":"Mohr","sequence":"additional","affiliation":[{"name":"Department of Neurology, Columbia University, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Morgan","sequence":"additional","affiliation":[{"name":"Macquarie University, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Moayeri","sequence":"additional","affiliation":[{"name":"Santa Barbara Cottage Hospital, Santa Barbara, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G.","family":"Zaroff","sequence":"additional","affiliation":[{"name":"Kaiser Permanente San Francisco Medical Center, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco A.","family":"Stefani","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurosurgery, Hospital de Clinicas de Porto Alegre, Porto Alegre, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolin","family":"Chen","sequence":"additional","affiliation":[{"name":"Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanli","family":"Zhao","sequence":"additional","affiliation":[{"name":"Beijing Tiantan Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rustam","family":"Al-Shahi Salman","sequence":"additional","affiliation":[{"name":"Institute for Neuroscience and Cardiovascular Research, The University of Edinburgh, Edinburgh, Great Britain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"noi250066r1","doi-asserted-by":"publisher","first-page":"b3016","DOI":"10.1136\/bmj.b3016","article-title":"Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis.","volume":"339","author":"Morris","year":"2009","journal-title":"BMJ"},{"issue":"4","key":"noi250066r2","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1161\/STROKEAHA.109.572495","article-title":"Radiological investigation of spontaneous intracerebral hemorrhage: systematic review and trinational survey.","volume":"41","author":"Cordonnier","year":"2010","journal-title":"Stroke"},{"issue":"12","key":"noi250066r3","doi-asserted-by":"publisher","first-page":"3654","DOI":"10.1161\/STROKEAHA.119.025783","article-title":"Nontraumatic pediatric intracerebral hemorrhage.","volume":"50","author":"Boulouis","year":"2019","journal-title":"Stroke"},{"issue":"Pt 2","key":"noi250066r4","first-page":"537","article-title":"Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies.","volume":"132","author":"van Beijnum","year":"2009","journal-title":"Brain"},{"issue":"2","key":"noi250066r5","doi-asserted-by":"publisher","first-page":"437","DOI":"10.3171\/2012.10.JNS121280","article-title":"Natural history of cerebral arteriovenous malformations: a meta-analysis.","volume":"118","author":"Gross","year":"2013","journal-title":"J Neurosurg"},{"issue":"9917","key":"noi250066r6","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/S0140-6736(13)62302-8","article-title":"Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicenter, nonblinded, randomized trial.","volume":"383","author":"Mohr","year":"2014","journal-title":"Lancet"},{"issue":"8","key":"noi250066r7","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1161\/STR.0000000000000134","article-title":"Management of brain arteriovenous malformations: a scientific statement for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"48","author":"Derdeyn","year":"2017","journal-title":"Stroke"},{"issue":"5","key":"noi250066r8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1227\/00006123-199511000-00001","article-title":"Simple risk predictions for arteriovenous malformation hemorrhage.","volume":"37","author":"Kondziolka","year":"1995","journal-title":"Neurosurgery"},{"issue":"4","key":"noi250066r9","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1227\/00006123-200004000-00056","article-title":"Simple risk predictions for arteriovenous malformation hemorrhage.","volume":"46","author":"Brown","year":"2000","journal-title":"Neurosurgery"},{"issue":"7","key":"noi250066r10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(20)30181-2","article-title":"Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicenter, nonblinded, randomized controlled trial.","volume":"19","author":"Mohr","year":"2020","journal-title":"Lancet Neurol"},{"issue":"7","key":"noi250066r11","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1161\/STROKEAHA.112.652032","article-title":"A perfect storm: how a randomized trial of unruptured brain arteriovenous malformations\u2019 (ARUBA\u2019s) trial design challenges notions of external validity.","volume":"43","author":"Cockroft","year":"2012","journal-title":"Stroke"},{"issue":"9","key":"noi250066r12","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.1161\/STROKEAHA.114.006519","article-title":"The case against a randomized trial of unruptured brain arteriovenous malformations: misinterpretation of a flawed study.","volume":"45","author":"Bambakidis","year":"2014","journal-title":"Stroke"},{"issue":"2","key":"noi250066r13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.3171\/2015.6.JNS15619","article-title":"Responses to ARUBA: a systematic review and critical analysis for the design of future arteriovenous malformation trials.","volume":"126","author":"Magro","year":"2017","journal-title":"J Neurosurg"},{"issue":"11","key":"noi250066r14","doi-asserted-by":"publisher","first-page":"867","DOI":"10.2471\/BLT.07.045120","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"85","author":"von Elm","year":"2007","journal-title":"Bull World Health Organ"},{"issue":"16","key":"noi250066r15","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD statement.","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"issue":"6","key":"noi250066r16","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1161\/01.STR.32.6.1430","article-title":"Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials.","volume":"32","author":"Atkinson","year":"2001","journal-title":"Stroke"},{"issue":"3","key":"noi250066r17","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1161\/01.STR.0000258355.23810.c6","article-title":"Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis.","volume":"38","author":"Banks","year":"2007","journal-title":"Stroke"},{"key":"noi250066r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"2","key":"noi250066r19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support.","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"noi250066r20","doi-asserted-by":"publisher","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting.","volume":"340","author":"Riley","year":"2010","journal-title":"BMJ"},{"issue":"4","key":"noi250066r22","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1001\/jamaneurol.2023.5663","article-title":"Trends in AVM-associated intracranial hemorrhage in the US, 2000-2019.","volume":"81","author":"Giantini-Larsen","year":"2024","journal-title":"JAMA Neurol"},{"issue":"1","key":"noi250066r23","doi-asserted-by":"publisher","DOI":"10.1161\/SVIN.122.000442","article-title":"Increase in Ruptured Cerebral Arteriovenous Malformations and Mortality in the United States: Unintended Consequences of the ARUBA Trial?","volume":"3","author":"Dicpinigaitis","year":"2023","journal-title":"Stroke Vasc Interv Neurol"},{"issue":"8","key":"noi250066r24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1136\/jnis-2022-019110","article-title":"National reduction in cerebral arteriovenous malformation treatment correlated with increased rupture incidence.","volume":"15","author":"Luther","year":"2023","journal-title":"J Neurointerv Surg"},{"issue":"12","key":"noi250066r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106807","article-title":"Impact of ARUBA trial on trends and outcomes in symptomatic nonruptured brain AVMs: a national sample analysis.","volume":"31","author":"Patel","year":"2022","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"7","key":"noi250066r26","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1212\/WNL.0000000000000688","article-title":"Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors.","volume":"83","author":"Kim","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"noi250066r27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3171\/2024.5.JNS24623","article-title":"Conservative management of brain arteriovenous malformations: results of the prospective observation registry of a pragmatic trial.","volume":"142","author":"Darsaut","year":"2024","journal-title":"J Neurosurg"},{"issue":"1","key":"noi250066r28","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s10143-023-01971-z","article-title":"Angiographic factors leading to hemorrhage in AVMs: a systematic review and meta-analysis.","volume":"46","author":"Koester","year":"2023","journal-title":"Neurosurg Rev"},{"issue":"4","key":"noi250066r29","doi-asserted-by":"publisher","DOI":"10.3171\/2020.7.FOCUS20464","article-title":"Surgical selection and outcomes among elderly patients with brain arteriovenous malformations.","volume":"49","author":"Burkhardt","year":"2020","journal-title":"Neurosurg Focus"},{"issue":"3","key":"noi250066r30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.1070","article-title":"Development and validation of a scoring system for hemorrhage risk in brain arteriovenous malformations.","volume":"6","author":"Chen","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"7","key":"noi250066r31","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1161\/STROKEAHA.119.025054","article-title":"R2eD AVM score.","volume":"50","author":"Feghali","year":"2019","journal-title":"Stroke"},{"issue":"2","key":"noi250066r32","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/neuros\/nyab108","article-title":"External validation of the R2eD AVM score to predict the likelihood of rupture presentation of brain arteriovenous malformations.","volume":"89","author":"Bird","year":"2021","journal-title":"Neurosurgery"},{"issue":"1","key":"noi250066r33","doi-asserted-by":"publisher","first-page":"W1","DOI":"10.7326\/M18-3668","article-title":"The Predictive Approaches to Treatment effect Heterogeneity (PATH) statement: explanation and elaboration.","volume":"172","author":"Kent","year":"2020","journal-title":"Ann Intern Med"},{"key":"noi250066r21","volume-title":"Stata Statistical Software: Release 18","author":"StataCorp","year":"2023"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/articlepdf\/2839512\/jamaneurology_kim_2025_oi_250066_1764183381.19686.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:01:04Z","timestamp":1765209664000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaneurology\/fullarticle\/2839512"}},"subtitle":["The Multicenter Arteriovenous Malformation Research Study (MARS)"],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2025.3581","relation":{},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}